Singapore will lift restrictions for all vaccinated travelers beginning April 1.
Travelers need not undergo a quarantine, as long as they take a pre-departure test.
Singapore Prime Minister Lee Hsien Loong hailed the development as a "major milestone" in the aviation hub's efforts to live with COVID-19 and would reconnect Singapore with the world.
Only travelers from countries on a "restricted list" will face curbs, although there are currently none on the list.
A raft of other coronavirus measures was also eased, with people in Singapore no longer required to wear masks outside, and people permitted to meet in groups of 10, up from five previously.
Singapore's approach is in contrast to rival financial hub Hong Kong, which required travelers to undergo lengthy quarantines in hotels.
Other Asia-Pacific countries that have recently announced an easing of travel restrictions include Indonesia, Malaysia, Australia, and New Zealand.


Colombia Opens New Investigation Into Former President Álvaro Uribe Over Paramilitary Allegations
Trump and Iran Sign Framework Peace Deal in France Amid Ongoing Middle East Tensions
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Canada Imposes 10% Tariff on Canned Vegetable Imports to Protect Domestic Industry
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination
Yen Near 40-Year Lows Despite BOJ Rate Hike, Markets Brace for Possible Intervention
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
BHP Shares Fall as Jansen Potash Project Costs Surge
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Italy’s Economy Outpaces Eurozone Peers as Investment Spending Fuels Growth
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
Why the future of marijuana legalization remains hazy despite high public support
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



